Review of Operations Directors’ Report Chairman’s Letter CEO’s Report Financial Report Shareholder Information 22 SHARE-BASED PAYMENTS The following share-based payment arrangements existed at 30 June 2026: Number of Options Exercise Price ($) Granted Date Status Vested Date Expiry Date Conditions Note 50,000 $0.82 2-Nov-22 Vested 2-Nov-23 2-Nov-26 Yes 1-4 50,000 $0.82 2-Nov-22 Vested 2-Nov-24 2-Nov-26 Yes 1-4 50,000 $0.82 2-Nov-22 Vested 2-Nov-25 2-Nov-26 Yes 1-4 166,667 $1.08 15-Dec-22 Vested 15-Dec-23 15-Dec-26 Yes 1-4 166,667 $1.08 15-Dec-22 Vested 15-Dec-24 15-Dec-26 Yes 1-4 166,666 $1.08 15-Dec-22 Vested 15-Dec-25 15-Dec-26 Yes 1-4 125,001 $0.845 28-Sep-23 Vested 28-Sep-24 28-Sep-27 Yes 1-4 125,000 $0.845 28-Sep-23 Vested 28-Sep-25 28-Sep-27 Yes 1-4 99,999 $0.845 28-Sep-23 Granted 28-Sep-26 28-Sep-27 Yes 1-4 1,075,000 $0.89 29-Nov-23 Vested 29-Nov-24 29-Nov-26 Yes 1-4 1,075,000 $0.89 29-Nov-23 Vested 29-May-25 29-May-27 Yes 1-4 1,075,000 $0.89 29-Nov-23 Vested 29-Nov-25 29-Nov-27 Yes 1-4 333,336 $1.00 29-Nov-24 Vested 29-Nov-25 29-Nov-28 Yes 1-4 333,332 $1.00 29-Nov-24 Granted 29-Nov-26 29-Nov-28 Yes 1-4 333,332 $1.00 29-Nov-24 Granted 29-Nov-27 29-Nov-28 Yes 1-4 50,000 $0.61 7-Apr-25 Vested 7-Apr-26 7-Apr-29 Yes 1-4 50,000 $0.61 7-Apr-25 Granted 7-Apr-27 7-Apr-29 Yes 1-4 50,000 $0.61 7-Apr-25 Granted 7-Apr-28 7-Apr-29 Yes 1-4 183,333 $0.506 18-Dec-25 Granted 18-Dec-26 18-Dec-30 Yes 1-4 183,333 $0.506 18-Dec-25 Granted 18-Dec-27 18-Dec-30 Yes 1-4 183,334 $0.506 18-Dec-25 Granted 18-Dec-28 18-Dec-30 Yes 1-4 50,000 $0.596 12-Jan-26 Granted 12-Jan-27 12-Jan-30 Yes 1-4 50,000 $0.596 12-Jan-26 Granted 12-Jan-28 12-Jan-30 Yes 1-4 50,000 $0.596 12-Jan-26 Granted 12-Jan-29 12-Jan-30 Yes 1-4 6,075,000 Total ESOP Options Listed Options 9,128,913 $1.00 9-Jul-24 Vested 9-Jul-24 8-Jul-26 No 250,000 $1.00 28-Aug-24 Vested 28-Aug-24 8-Jul-26 No 375,000 $1.00 9-Oct-24 Vested 9-Oct-24 8 Jul-26 No 9,753,913 Total Listed Options Listed options expired subsequent to 30 June 2026, on 8 July 2026. Notes: 1. Issued under the terms of the INOVIQ Incentive Option Plan (ESOP). 2. Upon termination of employment, vested options expire 60 days after termination of employment other than upon death, retirement, disability, or at Board discretion. Options are to be allowed to remain exercisable until expiry upon retirement or disability. Upon death, or mental incapacity, options can be transferred to an estate, or next of kin, and allowed to remain exercisable until expiry. In case of a change of control unvested options which have not expired are deemed to have satisfied the vesting conditions. 3. Vesting basis: to remain employed by INOVIQ up until vesting date. 4. ESOP options are not subject to performance conditions however are subject to continuation of employment, except in the event of forced resignation due to illness/death or retirement where the Board may exercise discretion to allow unvested options to continue onto expiry. All options granted are in respect of ordinary shares in INOVIQ Limited and confer a right of one ordinary share for each option held. Per the terms and conditions of the Incentive Option Plan, directors retain the right to vary the terms of issued options as long as the variation does not result in a lessening of the holder’s rights. 55 Annual Report 2026
RkJQdWJsaXNoZXIy MjE2NDg3